Fast Disintegrating Combination Tablet of Taste Masked Levocetrizine Dihydrochloride and Montelukast Sodium: Formulation Design, Development, and Characterization

<table class="table-group" id="tab9"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Optimized ratio of drug and resin</td><td align="center">% Drug loading</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Kyron-T-104 (1 : 4)</td><td align="center">85.26 ± 1.32</td></tr><tr><td align="left">Tulsion-412 (1 : 5)</td><td align="center">80.93 ± 1.48</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Relation between drug-resin ratio and drug loading.

Journal of Pharmaceutics

tab9

Table 9

Table 9: Fast Disintegrating Combination Tablet of Taste Masked Levocetrizine Dihydrochloride and Montelukast Sodium: Formulation Design, Development, and Characterization 

Table 9 | Fast Disintegrating Combination Tablet of Taste Masked Levocetrizine Dihydrochloride and Montelukast Sodium: Formulation Design, Development, and Characterization 